
Public Reporting
Accountable Care Public Reporting Information
Accountable Care Organization (ACO) Name and Location
Freedom Healthcare Alliance, LLC
8761 Dorchester Road
Suite 230
North Charleston, SC 29420
ACO Primary Contact
Primary Contact Name: Lissa Lara, CEO
Primary Contact Phone Number: 843-412-1590
Primary Contact Email Address: lissalara@qualityhealthcaredevelopment.com
Organizational Information
ACO PARTICIPANTS | ACO PARTICIPANT IN JOINT-VENTURE (Enter Y or N) |
James T Martin Jr MD | N |
Liberty Doctors, LLC | N |
Dorchester Medical Associates | N |
Internal Medicine of Walterboro | N |
Lake City Family Medicine, LLC | N |
ACO Governing Body
Member First Name | Member Last Name | Title/Position | Member’s Voting Power – Expressed as a percentage or number | Membership Type | ACO Participant TIN Legal Business Name/DBA, if Applicable |
Lissa | Lara | CEO | 16 | Other | N/A |
Hugh | Durrence | MD CMO Board Member | 13 | ACO Participant Representative | Liberty Doctors, LLC |
Donald | Hanna | MD Board Member | 13 | ACO Participant Representative | Liberty Doctors, LLC |
Douglas | Gleaton | MD Board Member | 13 | ACO Participant Representative | Liberty Doctors, LLC |
John | Forney | MD Board Member | 13 | ACO Participant Representative | Liberty Doctors, LLC |
David | Price | MD Board Member | 6 | Medicare Beneficiary Representative | N/A |
James | Martin Jr | MD Board Member | 13 | ACO Participant Representative | James T Martin Jr., LLC |
Jeffrey | Kramer | MD Board Member | 13 | ACO Participant Representative | Internal Medicine of Walterboro |
KEY ACO CLINICAL AND ADMINISTRATIVE LEADERSHIP:
Lissa Lara | ACO Executive |
Hugh Durrence | Medical Director |
John Park | Compliance Officer |
Katherine Hill | Quality Assurance/Improvement Officer |
Associated committees and committee leadership:
Committee Name | Committee Leader Name and Position |
Finance Committee | Lissa Lara, CEO Hugh Durence, RPh, MD, Medical Director |
Quality Committee | Lissa Lara, CEO Hugh Durence, RPh, MD, Medical Director Katherine Hill, Quality Assurance, Improvement Officer |
Compliance Committee | Lissa Lara, CEO Hugh Durence, RPh, MD, Medical Director John Park, Compliance Officer |
30Types of ACO participants, or combinations of participants, that formed the ACO:
- Primary Care Physicians
- Obstetrics and gynecology
Shared Savings and Losses
Amount of Shared Savings/Losses:
- Second Agreement Period
- Performance Year 2020, $2,960,193
- First Agreement Period
- Performance Year 2019, $921,888.92
Shared Savings Distribution:
- Second Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 60%
First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: 37%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 53%
- Performance Year 2020
Quality Performance Results
2020 Quality Performance Results:
ACO Quality Measure Number |
Measure Name |
Rate |
ACO Mean |
ACO-43 |
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) |
0.81 |
0.95 |
ACO-13 |
Falls: Screening for Future Fall Risk |
81.27 |
84.97 |
ACO-14 |
Preventive Care and Screening: Influenza Immunization |
66.13 |
76.03 |
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
76.47 |
81.67 |
ACO-18 |
Preventive Care and Screening: Screening for Depression and Follow-up Plan |
66.67 |
71.46 |
ACO-19 |
Colorectal Cancer Screening |
53.23 |
72.59 |
ACO-20 |
Breast Cancer Screening |
60.53 |
74.05 |
ACO-42 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
79.62 |
83.37 |
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
13.38 |
14.70 |
ACO-28 |
Hypertension (HTN): Controlling High Blood Pressure |
70.94 |
72.87 |
“Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.”
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Payment Rule Waivers
- Skilled Nursing Facility (SNF) 3-day Rule Waiver:
- Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.